Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and HIV-1. The Company’s core expertise lies in designing and developing new drugs that target a new class of viral proteins known as viroporins. Viroporins are found in a range of viruses, and include the p7 protein … Continue reading Technology